Somasundaram S, Simpson R, Rafi S, Shergill J K, Bjarnason I, Wrigglesworth J
Lineberger Comprehensive Cancer Center, CB#7295, University of North Carolina, Chapel Hill, NC 27599, USA.
BMC Gastroenterol. 2002 Apr 18;2:8. doi: 10.1186/1471-230x-2-8.
It has been suggested that one aspect of non-steroidal anti-inflammatory drugs induced intestinal damage is due to either uncoupling of mitochondrial oxidative phosphorylation or inhibition of electron transport. We investigated the latter possibility using electron paramagnetic resonance spectroscopy.
Electron paramagnetic studies of NSAIDS on sub-mitochondrial particles revealed that indomethacin, but not with nabumetone, bound to a site near to Complex I and ubiquinone to generate a radical species. Normal rats exhibited prominent [3Fe-4S]ox signals (g approximately 2.01) at 20 K. One hour after indomethacin there was a prominent, intense and broad absorption pattern at (g approximately 2.07) suggesting, appearance of radical species overlapping [3Fe-4S]ox and was unaffected by pretreatment with 2,4 diamino -6-hydroxy pyrimidine. At 24 hrs, when macroscopic ulcers were seen, there was a new signal due to a nitric oxide radical (NO*). In contrast, nabumetone and 2,4 diamino-6-hydroxy pyrimidine pre-treated animals receiving indomethacin exhibited electron paramagnetic resonance spectra identical to those of controls at 24 hrs and neither was associated with small intestinal ulcers. Indomethacin and 2,4 diamino hydroxy pyrimidine pre-treated rats, but not nabumetone, had increased intestinal permeability.
The results suggest that the in vivo effects of indomethacin modulate the mitochondrial respiratory chain directly at 1 h and 24 h through formation of nitric oxide. NO* appears to play an important role in the late pathogenic stages of NSAID enteropathy and may be the site for targeted treatment to reduce their toxicity.
有研究表明,非甾体抗炎药引起肠道损伤的一个原因是线粒体氧化磷酸化解偶联或电子传递受到抑制。我们使用电子顺磁共振波谱法研究了后一种可能性。
对非甾体抗炎药作用于亚线粒体颗粒的电子顺磁共振研究表明,吲哚美辛而非萘丁美酮,与复合体I和泛醌附近的位点结合以产生自由基。正常大鼠在20K时呈现出显著的[3铁-4硫]氧化信号(g约为2.01)。吲哚美辛给药1小时后,在(g约为2.07)处出现一个显著、强烈且宽泛的吸收模式,表明出现了与[3铁-4硫]氧化信号重叠的自由基,且不受2,4-二氨基-6-羟基嘧啶预处理的影响。在24小时时,当出现肉眼可见的溃疡时,由于一氧化氮自由基(NO*)出现了一个新信号。相比之下,接受吲哚美辛治疗的萘丁美酮和2,4-二氨基-6-羟基嘧啶预处理动物在24小时时的电子顺磁共振光谱与对照组相同,且两者均未出现小肠溃疡。吲哚美辛和2,4-二氨基羟基嘧啶预处理的大鼠而非萘丁美酮,肠道通透性增加。
结果表明,吲哚美辛在体内的作用在1小时和24小时时通过一氧化氮的形成直接调节线粒体呼吸链。NO*似乎在非甾体抗炎药肠病的晚期致病阶段起重要作用,可能是降低其毒性的靶向治疗位点。